Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial

Christopher P. Venner; Richard LeBlanc; Irwindeep Sandhu; Darrell White; Andrew R. Belch; Donna E. Reece; Christine Chen; Sean Dolan; Marc Lalancette; Martha Louzada; Andrea Kew; Arleigh McCurdy; Bethany Monteith; Tony Reiman; Gail McDonald; Max Sherry; Engin Gul; Bingshu E. Chen; Annette E. Hay

doi:10.1002/ajh.26147

Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial

Christopher P. Venner, Richard LeBlanc, Irwindeep Sandhu, Darrell White, Andrew R. Belch, Donna E. Reece, Christine Chen, Sean Dolan, Marc Lalancette, Martha Louzada, Andrea Kew, Arleigh McCurdy, Bethany Monteith, Tony Reiman, Gail McDonald, Max Sherry, Engin Gul, Bingshu E. Chen, Annette E. Hay

Engineering

科研成果: 期刊稿件 › 文章 › 同行评审

13 引用（Scopus）

源语言	英语
页（从-至）	552-560
页数	9
期刊	American Journal of Hematology
卷	96
期	5
DOI	https://doi.org/10.1002/ajh.26147
出版状态	已出版 - 5月 1 2021

!!!ASJC Scopus Subject Areas

血液学

访问文件

10.1002/ajh.26147

其它文件与链接

引用此

Venner, C. P., LeBlanc, R., Sandhu, I., White, D., Belch, A. R., Reece, D. E., Chen, C., Dolan, S., Lalancette, M., Louzada, M., Kew, A., McCurdy, A., Monteith, B., Reiman, T., McDonald, G., Sherry, M., Gul, E., Chen, B. E., & Hay, A. E. (2021). Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial. American Journal of Hematology, 96(5), 552-560. https://doi.org/10.1002/ajh.26147

Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial. / Venner, Christopher P.; LeBlanc, Richard; Sandhu, Irwindeep 等.
在: American Journal of Hematology, 卷 96, 号码 5, 01.05.2021, 页码 552-560.

科研成果: 期刊稿件 › 文章 › 同行评审

Venner, CP, LeBlanc, R, Sandhu, I, White, D, Belch, AR, Reece, DE, Chen, C, Dolan, S, Lalancette, M, Louzada, M, Kew, A, McCurdy, A, Monteith, B, Reiman, T, McDonald, G, Sherry, M, Gul, E, Chen, BE & Hay, AE 2021, 'Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial', American Journal of Hematology, 卷 96, 号码 5, 页码 552-560. https://doi.org/10.1002/ajh.26147

@article{ac7161f5b65e48518f36130670004124,

title = "Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial",

author = "Venner, {Christopher P.} and Richard LeBlanc and Irwindeep Sandhu and Darrell White and Belch, {Andrew R.} and Reece, {Donna E.} and Christine Chen and Sean Dolan and Marc Lalancette and Martha Louzada and Andrea Kew and Arleigh McCurdy and Bethany Monteith and Tony Reiman and Gail McDonald and Max Sherry and Engin Gul and Chen, {Bingshu E.} and Hay, {Annette E.}",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC.",

year = "2021",

month = may,

day = "1",

doi = "10.1002/ajh.26147",

language = "English",

volume = "96",

pages = "552--560",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma

T2 - Final results from the MCRN-003/MYX.1 single arm phase II trial

AU - Venner, Christopher P.

AU - LeBlanc, Richard

AU - Sandhu, Irwindeep

AU - White, Darrell

AU - Belch, Andrew R.

AU - Reece, Donna E.

AU - Chen, Christine

AU - Dolan, Sean

AU - Lalancette, Marc

AU - Louzada, Martha

AU - Kew, Andrea

AU - McCurdy, Arleigh

AU - Monteith, Bethany

AU - Reiman, Tony

AU - McDonald, Gail

AU - Sherry, Max

AU - Gul, Engin

AU - Chen, Bingshu E.

AU - Hay, Annette E.

PY - 2021/5/1

Y1 - 2021/5/1

UR - http://www.scopus.com/inward/record.url?scp=85104209850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104209850&partnerID=8YFLogxK

U2 - 10.1002/ajh.26147

DO - 10.1002/ajh.26147

M3 - Article

C2 - 33650179

AN - SCOPUS:85104209850

SN - 0361-8609

VL - 96

SP - 552

EP - 560

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 5

ER -

Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此